ACM
MRVI icon

Aquatic Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Aquatic Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,457
Closed -$135K – 1658
2025
Q4 		$135K Buy
+41,457
New +$140K ﹤0.01% 1090
2024
Q4 		– Sell
-38,100
Closed -$317K – 1513
2024
Q3 		$317K Buy
+38,100
New +$329K 0.01% 737
2024
Q2 		– Sell
-39,400
Closed -$342K – 1469
2024
Q1 		$342K Buy
+39,400
New +$267K 0.01% 639
2023
Q2 		– Sell
-3,200
Closed -$45K – 1605
2023
Q1 		$45K Buy
+3,200
New +$46K ﹤0.01% 913

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aquatic Capital Management's MRVI Position: Q1 2026 in Review

Aquatic Capital Management sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 41,457 shares — an estimated $135K sold.

Aquatic Capital Management first reported a position in MRVI in Q1 2023 and held it in 4 quarters. The position peaked at $342K in Q1 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Aquatic Capital Management reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 41,457 Maravai LifeSciences shares in Q1 2026, an estimated $135K.
  • Aquatic Capital Management first reported a position in Maravai LifeSciences in Q1 2023 and held it in 4 quarters.
  • Aquatic Capital Management's Maravai LifeSciences position peaked at $342K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.